Humacyte earnings were -$77.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest HUMA earnings report on Mar 31, 2025 announced Q1 2025 earnings of $39.1M, down 286.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HUMA reported annual earnings of -$148.7M, with 34.2% growth. The next HUMA earnings date is Aug 19, 2025.
On HUMA's earnings call on Invalid Date, Humacyte (NASDAQ: HUMA) reported Q1 2025 earnings per share (EPS) of $0.28, up 196.55% year over year. Total HUMA earnings for the quarter were $39.14 million. In the same quarter last year, Humacyte's earnings per share (EPS) was -$0.29.
The next HUMA earnings date is Invalid Date. Add HUMA to your watchlist to be reminded of Humacyte's next earnings date.
Is Humacyte profitable or losing money?
As of the last Humacyte earnings report, Humacyte is currently losing money. Humacyte's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$77.67 million, a 26.52% decrease year over year.
What was HUMA's earnings growth in the past year?
As of Humacyte's earnings date in Invalid Date, Humacyte's earnings has grown year over year. HUMA earnings in the past year totalled -$77.67 million.
What are Humacyte's earnings expectations?
The current EPS estimate for Humacyte's earnings report in Invalid Date is -$0.16.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.